Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IL-2発現に適したプラスミド
Document Type and Number:
Japanese Patent JP3710815
Kind Code:
B2
Abstract:
The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods. The plasmid consists essentially of an expression facilitating sequence derived from the immediate-early promoter region of CMV, an expression facilitating sequence derived from the transcriptional termination/polyadenylation signal sequence of the BGH gene, a sequence coding for the eukaryotic expression of an IL-2, possessing a bioactivity of the complete IL-2, operably linked to both of said expression facilitating augments eukaryotic expression compared to a wild-type IL-2 leader peptide. Optionally, the plasmid also includes a non-mammalian origin of replication and a sequence operably encoding a selectable marker.

Inventors:
Hobart, Peter, M.
Margaris, Mycal
Parker, Susanne, Yi.
Hathibi, Shrine
Application Number:
JP51887196A
Publication Date:
October 26, 2005
Filing Date:
November 28, 1995
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Baikal Incorporated
International Classes:
C12N15/09; A61K31/70; A61K35/76; A61K38/00; A61K38/20; A61K47/44; A61K48/00; A61P35/00; C07K14/55; C12N5/08; C12N15/26; C12N15/62; C12N15/85; C12P21/02; C12P21/04; (IPC1-7): C12N15/09; A61K35/76; A61K38/00; A61K48/00; A61P35/00; C07K14/55; C12P21/02
Domestic Patent References:
JP62278994A
Other References:
MONTGOMERY D. L. et al., Hetetologous and Homologous Protection Against Influenza A by DNA Vaccination:Optimization of DNA Ve, DNA AND CELL BIOLOGY, 1993年,VOl.12,No.9, 777-783
PARKER S. E. et al., DIRECT DELIVERY OF CYTOKINE GENES INTO TUMORS FOR CANCER IMMUNOTHERAPY, JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 18A, 米国,1994年 1月,244
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazuhiro Nakamura
Masaya Nishiyama